{"product_id":"new-developments-in-understanding","title":"New Developments in Understanding Chronic Illnesses: The Role of Immune Dysfunction and Infections 2023","description":"\u003ch3\u003eNew Developments in Understanding Chronic Illnesses: The Role of Immune Dysfunction and Infections\u003c\/h3\u003e\n\u003cdiv\u003eThere are over 20 million Americans suffering from a group of chronic disabling disorders who are diagnosed without a clear elucidation of pathophysiologic mechanisms. Fibromyalgia, Myalgic Encephalomyelitis\/ Chronic Fatigue Syndrome (ME\/CFS), Neuropsychiatric illnesses, Posttreatment Lyme Syndrome, Pediatric Acute on Neuropsychiatric Syndrome (PANDAS\/PANS).\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eTarget Audience\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Allergy\/Immunology, Family Medicine, Infectious Disease, Internal Medicine, Neurology, Pain Medicine, Pediatrics, Psychiatry, Psychology , Rheumatology\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eProfessions\u003c\/em\u003e – Non-Physician, Nurse, Nurse Practitioner, Physician\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003ch2 class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eThere are over 20 million Americans suffering from a group of chronic disabling disorders who are diagnosed without a clear elucidation of pathophysiologic mechanisms. Fibromyalgia, Myalgic Encephalomyelitis\/ Chronic Fatigue Syndrome (ME\/CFS), Neuropsychiatric illnesses, Posttreatment Lyme Syndrome, Pediatric Acute on Neuropsychiatric Syndrome (PANDAS\/PANS).\u003c\/li\u003e\n\u003cli\u003eAdding to this massive disease burden the CDC now estimates that of the 40% of Americans who were infected with COVID-19 1 in 5 continue to suffer with what is now referred to as Post-acute sequalae of COVID (PASC). Research has demonstrated that common to all of these conditions is dysregulation of the immune system resulting from an infectious insult. Dramatic advances have occurred in our understanding of all of these conditions as a result of COVID. We are entering an incredibly exciting period in medicine where these diseases are beginning to coalesce around an understanding of shared pathophysiology. We are entering a period of true hope for those millions who are suffering where we will finally be able to provide comprehensive solutions for their illness.\u003c\/li\u003e\n\u003cli\u003eThis conference will bring together some of the leading researchers and clinicians from around the world to discuss the advances in our understanding of these conditions and breakthroughs in diagnostic and treatment options.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003ch2 class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/h2\u003e\n\u003ch5\u003eAfter completing this activity, the participant will be able to:\u003c\/h5\u003e\n\u003col\u003e\n\u003cli\u003eSummarize the role of the innate and adaptive immune system in chronic disease.\u003c\/li\u003e\n\u003cli\u003eExplain biological mechanisms of how infections incite immune dysfunction resulting in chronic disease.\u003c\/li\u003e\n\u003cli\u003eDescribe new diagnostic testing and biomarkers for defining and identifying immune dysfunction in chronic illness.\u003c\/li\u003e\n\u003cli\u003eIdentify clinical and case study examples using new and repositioned treatment modalities that have been shown to be effective in treating immune-mediated chronic disorders secondary to infection.\u003c\/li\u003e\n\u003cli\u003eSummarize long haul covid and it’s pathophysiology and new diagnostic and treatment modalities.\u003c\/li\u003e\n\u003cli\u003eDescribe a new understanding of fibromyalgia as an immunologic disorder and the role of the immune system in Myalgic Encephalomyelitis\/ Chronic Fatigue Syndrome (ME\/CFS).\u003c\/li\u003e\n\u003cli\u003eRecognize the role of infections and immune dysfunction as the cause of other neurologic, psychiatric, and behavioral disorders.\u003c\/li\u003e\n\u003cli\u003eExplain the role of gut microbiome in health and immune dysfunction.\u003c\/li\u003e\n\u003cli\u003eIdentify the roles and responsibilities of members of the healthcare team involved in the collaborative care of patients with atypical immunological diseases.\u003c\/li\u003e\n\u003cli\u003eIntegrate a team-based approach in the care of patients with atypical immunological diseases.\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eNDUCI2023_brochureV2.pdf\u003c\/li\u003e\n\u003cli\u003eSession I Acute and Chronic Neurological Disorders in COVID-19 Potential Mechanisms of Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSession I NIH Data Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME CFS) Data.mp4\u003c\/li\u003e\n\u003cli\u003eSession I Opening and Epidemiology How Big is the Problem Immune Dysregulation Secondary to Infections as a Cause of Chronic Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSession I The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis Chronic Fatigue Syndrome A Critical Review.mp4\u003c\/li\u003e\n\u003cli\u003eSession II Introduction and Long Covid and Long Lyme Mental Health Implications.mp4\u003c\/li\u003e\n\u003cli\u003eSession II Long Covid and Long Lyme Mental Health Implications.mp4\u003c\/li\u003e\n\u003cli\u003eSession II Neuropsychiatric Diseases, Immune Dysfunction \u0026amp; Infections PANS PANDAS, POTS, PTLDS, Immune Dysfunction and Imaging \u0026amp; Testing for AEIE.mp4\u003c\/li\u003e\n\u003cli\u003eSession II The Neuroimmunology of Social Stress Induced Sensitization.mp4\u003c\/li\u003e\n\u003cli\u003eSession III Introduction and Chronic Pain and Infection Mechanisms, Causes, Conditions, Treatments, and Controversies.mp4\u003c\/li\u003e\n\u003cli\u003eSession III The Autoimmune Aeitiology of Unexplained Chronic Pain.mp4\u003c\/li\u003e\n\u003cli\u003eSession III The Brain and Gut Connection More Impactful Than You Think.mp4\u003c\/li\u003e\n\u003cli\u003eSession IV Introduction and Current and Practical Techniques to Support the Gut Microbiome.mp4\u003c\/li\u003e\n\u003cli\u003eSession IV Myalgic Encephalomyelitis Chronic Fatigue Syndrome (ME CFS).mp4\u003c\/li\u003e\n\u003cli\u003eSession V Introduction and Diagnosis and Treatment of Chronic Inflammatory Conditions including Long COVID and ME-CFS.mp4\u003c\/li\u003e\n\u003cli\u003eSession V Modulation of the Acquired Immune System Autoimmune Therapy Stem Cells Topic.mp4\u003c\/li\u003e\n\u003cli\u003eSession VI Autoimmune Epilepsy Biomarker Study.mp4\u003cbr\u003eSession VI Introduction and Molecular Mimicry The Infection Connection to the Immune System and Chronic Disorders.mp4\u003c\/li\u003e\n\u003cli\u003eSession VI The Axis of Infectious Immune as a Player in Neuro Immune Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSession VII Brain Changes and Clinical Outcome Correlates in Post-Treatment Lyme Disease.mp4\u003c\/li\u003e\n\u003cli\u003eSession VII Introduction and The Clinical Significance of Metabolic Immune Interactions Implication for Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eSession VII Long Lyme Opportunities for Prevention and Treatment.mp4\u003c\/li\u003e\n\u003cli\u003eSession VII Nutritional Supplements for Immune and Mitochondrial Dysfunction.mp4\u003c\/li\u003e\n\u003cli\u003eSession VII What is Post-Treatment Lyme Disease Syndrome.mp4\u003c\/li\u003e\n\u003cli\u003eSession VIII Denied Due to Lack of Medical Necessity Preventing \u0026amp; Responding to Insurance Denials for PANS PANDAS Treatments.mp4\u003c\/li\u003e\n\u003cli\u003eSession VIII Introduction and Denied Due to Lack of Medical Necessity Preventing \u0026amp; Responding to Insurance Denials for PANS PANDAS Treatments.mp4\u003c\/li\u003e\n\u003cli\u003eSession VIII Panel Post Treatment Lyme-PANS PANDAS.mp4\u003c\/li\u003e\n\u003cli\u003eSession VIII Panel Treatment.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954369794146,"sku":"MED-AMB02059","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/MedStar-Health-New-Developments-in-Understanding-Chronic-Illnesses-2023.jpg?v=1779374783","url":"https:\/\/meducourse.com\/products\/new-developments-in-understanding","provider":"Meducourse","version":"1.0","type":"link"}